Predicting Cardiovascular Disease Risk using Photoplethysmography and Deep Learning
Authors:
Wei-Hung Weng,
Sebastien Baur,
Mayank Daswani,
Christina Chen,
Lauren Harrell,
Sujay Kakarmath,
Mariam Jabara,
Babak Behsaz,
Cory Y. McLean,
Yossi Matias,
Greg S. Corrado,
Shravya Shetty,
Shruthi Prabhakara,
Yun Liu,
Goodarz Danaei,
Diego Ardila
Abstract:
Cardiovascular diseases (CVDs) are responsible for a large proportion of premature deaths in low- and middle-income countries. Early CVD detection and intervention is critical in these populations, yet many existing CVD risk scores require a physical examination or lab measurements, which can be challenging in such health systems due to limited accessibility. Here we investigated the potential to…
▽ More
Cardiovascular diseases (CVDs) are responsible for a large proportion of premature deaths in low- and middle-income countries. Early CVD detection and intervention is critical in these populations, yet many existing CVD risk scores require a physical examination or lab measurements, which can be challenging in such health systems due to limited accessibility. Here we investigated the potential to use photoplethysmography (PPG), a sensing technology available on most smartphones that can potentially enable large-scale screening at low cost, for CVD risk prediction. We developed a deep learning PPG-based CVD risk score (DLS) to predict the probability of having major adverse cardiovascular events (MACE: non-fatal myocardial infarction, stroke, and cardiovascular death) within ten years, given only age, sex, smoking status and PPG as predictors. We compared the DLS with the office-based refit-WHO score, which adopts the shared predictors from WHO and Globorisk scores (age, sex, smoking status, height, weight and systolic blood pressure) but refitted on the UK Biobank (UKB) cohort. In UKB cohort, DLS's C-statistic (71.1%, 95% CI 69.9-72.4) was non-inferior to office-based refit-WHO score (70.9%, 95% CI 69.7-72.2; non-inferiority margin of 2.5%, p<0.01). The calibration of the DLS was satisfactory, with a 1.8% mean absolute calibration error. Adding DLS features to the office-based score increased the C-statistic by 1.0% (95% CI 0.6-1.4). DLS predicts ten-year MACE risk comparable with the office-based refit-WHO score. It provides a proof-of-concept and suggests the potential of a PPG-based approach strategies for community-based primary prevention in resource-limited regions.
△ Less
Submitted 9 May, 2023;
originally announced May 2023.
Bayesian Estimation of Population-Level Trends in Measures of Health Status
Authors:
Mariel M. Finucane,
Christopher J. Paciorek,
Goodarz Danaei,
Majid Ezzati
Abstract:
Improving health worldwide will require rigorous quantification of population-level trends in health status. However, global-level surveys are not available, forcing researchers to rely on fragmentary country-specific data of varying quality. We present a Bayesian model that systematically combines disparate data to make country-, region- and global-level estimates of time trends in important heal…
▽ More
Improving health worldwide will require rigorous quantification of population-level trends in health status. However, global-level surveys are not available, forcing researchers to rely on fragmentary country-specific data of varying quality. We present a Bayesian model that systematically combines disparate data to make country-, region- and global-level estimates of time trends in important health indicators. The model allows for time and age nonlinearity, and it borrows strength in time, age, covariates, and within and across regional country clusters to make estimates where data are sparse. The Bayesian approach allows us to account for uncertainty from the various aspects of missingness as well as sampling and parameter uncertainty. MCMC sampling allows for inference in a high-dimensional, constrained parameter space, while providing posterior draws that allow straightforward inference on the wide variety of functionals of interest. Here we use blood pressure as an example health metric. High blood pressure is the leading risk factor for cardiovascular disease, the leading cause of death worldwide. The results highlight a risk transition, with decreasing blood pressure in high-income regions and increasing levels in many lower-income regions.
△ Less
Submitted 19 May, 2014;
originally announced May 2014.